19-53050162-G-A

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_001191055.2(ERVV-2):​c.911G>A​(p.Arg304Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000723 in 1,441,736 control chromosomes in the GnomAD database, including 27 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/16 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00037 ( 1 hom., cov: 22)
Exomes 𝑓: 0.00076 ( 26 hom. )

Consequence

ERVV-2
NM_001191055.2 missense

Scores

12

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.365
Variant links:
Genes affected
ERVV-2 (HGNC:39051): (endogenous retrovirus group V member 2, envelope) Many different human endogenous retrovirus (HERV) families are expressed in normal placental tissue at high levels, suggesting that HERVs are functionally important in reproduction. This gene is part of an HERV provirus on human chromosome 19 that has inactivating mutations in the gag and pol genes. This envelope glycoprotein gene appears to have been selectively preserved. The gene's protein product is expressed in the placenta and acts as a syncytin in Old World monkeys, but has lost the fusogenic activity in humans and other primate lineages. [provided by RefSeq, Jun 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.034003496).
BS2
High Homozygotes in GnomAdExome4 at 26 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
ERVV-2NM_001191055.2 linkuse as main transcriptc.911G>A p.Arg304Gln missense_variant 2/2 ENST00000601417.3 NP_001177984.1 B6SEH9M9QSX5

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
ERVV-2ENST00000601417.3 linkuse as main transcriptc.911G>A p.Arg304Gln missense_variant 2/24 NM_001191055.2 ENSP00000472919.1 B6SEH9

Frequencies

GnomAD3 genomes
AF:
0.000367
AC:
54
AN:
146966
Hom.:
1
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.000153
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000696
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000196
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000688
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000303
AC:
35
AN:
115562
Hom.:
0
AF XY:
0.000302
AC XY:
19
AN XY:
62826
show subpopulations
Gnomad AFR exome
AF:
0.000165
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000551
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000671
Gnomad OTH exome
AF:
0.000564
GnomAD4 exome
AF:
0.000764
AC:
989
AN:
1294770
Hom.:
26
Cov.:
29
AF XY:
0.000692
AC XY:
444
AN XY:
641732
show subpopulations
Gnomad4 AFR exome
AF:
0.000206
Gnomad4 AMR exome
AF:
0.0000291
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000265
Gnomad4 FIN exome
AF:
0.0000297
Gnomad4 NFE exome
AF:
0.000965
Gnomad4 OTH exome
AF:
0.000219
GnomAD4 genome
AF:
0.000367
AC:
54
AN:
146966
Hom.:
1
Cov.:
22
AF XY:
0.000294
AC XY:
21
AN XY:
71380
show subpopulations
Gnomad4 AFR
AF:
0.000153
Gnomad4 AMR
AF:
0.0000696
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000196
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000688
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000474
Hom.:
0
Bravo
AF:
0.000340
ExAC
AF:
0.000164
AC:
2

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsDec 19, 2022The c.911G>A (p.R304Q) alteration is located in exon 2 (coding exon 1) of the ERVV-2 gene. This alteration results from a G to A substitution at nucleotide position 911, causing the arginine (R) at amino acid position 304 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.57
T
BayesDel_noAF
Benign
-0.67
CADD
Benign
13
DANN
Benign
0.68
DEOGEN2
Benign
0.0014
T
FATHMM_MKL
Benign
0.0053
N
LIST_S2
Benign
0.55
T
M_CAP
Benign
0.020
T
MetaRNN
Benign
0.034
T
MutationAssessor
Benign
0.41
N
PrimateAI
Benign
0.39
T
Sift4G
Benign
0.16
T
Vest4
0.072
MVP
0.13
GERP RS
0.42
Varity_R
0.058
gMVP
0.12

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs780761856; hg19: chr19-53553415; COSMIC: COSV105942403; API